Approval · Notice of Compliance 4891 · 1995
SYN-BROMOCRIPTINE: Notice of Compliance 4891
Issued April 27, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4891
- Date
- April 27, 1995
- Company
- Syncare Pharmaceutical Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Revised product monograph: removal of the indication of inhibition of lactatim
- Therapeutic class
- Proalctin inhibitor, growth hormone suppressant in acromegaly, adjunctive medication in parkinson's disease
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYN-BROMOCRIPTINE | Not yet assigned | — |
Medicinal ingredients
- BROMOCRIPTINE MESYLATE 2.5 MG per TAB
- BROMOCRIPTINE MESYLATE 5 MG per CAP